Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vicplas International's Enterprise Value is S$76.8 Mil.
Vicplas International's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 was S$-3.1 Mil. Therefore, Vicplas International's EV-to-EBIT ratio for today is -24.92.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Vicplas International's Enterprise Value is S$76.8 Mil.
Vicplas International's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 was S$5.3 Mil. Therefore, Vicplas International's EV-to-EBITDA ratio for today is 14.39.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Vicplas International (SGX:569) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Vicplas International's current Enterprise Value is S$76.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vicplas International's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 was S$-3.1 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Vicplas International's EV-to-EBITDA for today is:
Vicplas International's current Enterprise Value is S$76.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vicplas International's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 was S$5.3 Mil.
Vicplas International's current Enterprise Value is S$76.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vicplas International's Revenue for the trailing twelve months (TTM) ended in Jan. 2026 was S$123.8 Mil.
Vicplas International's current Enterprise Value is S$76.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vicplas International's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2026 was S$2.0 Mil.
Vicplas International's current Enterprise Value is S$76.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vicplas International's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 was S$-2.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicplas International Enterprise Value Related Terms
Vicplas International Enterprise Value Historical Data
* Premium members only.
The historical data trend for Vicplas International's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:569 vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Vicplas International's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicplas International Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Vicplas International's Enterprise Value falls into.
Vicplas International Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Vicplas International's Enterprise Value for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicplas International (SGX:569) has a Enterprise Value of S$76.8 Mil as of Aug. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Vicplas International and its competitors.
Is Vicplas International's Enterprise Value too high?
Vicplas International's current Enterprise Value is S$76.8 Mil.
How does Vicplas International's Enterprise Value compare to ABT and SYK?
Vicplas International's Enterprise Value of S$76.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Vicplas International and its competitors. Vicplas International's current Enterprise Value is S$76.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicplas International stock overvalued right now?
Based on GuruFocus' analysis, Vicplas International (SGX:569) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.11, compared to a current price of S$0.08 — trading 30% below its estimated fair value. The current Enterprise Value is S$76.8 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Vicplas International (SGX:569), the current Enterprise Value is S$76.8 Mil as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, Mexico, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:569 has been successfully added to your 
